Hemodynamic transesophageal echocardiography after left ventricular assist device implantation

Area of Science:

• Cardiology
• Critical Care Medicine
• Medical Devices

Background:

• Continuous flow left ventricular assist devices (CF-LVADs) are crucial for end-stage heart failure management.
• Assessing hemodynamic status in CF-LVAD patients is vital for optimizing outcomes.
• Transesophageal echocardiography (TEE) offers detailed cardiac visualization, but its role in CF-LVAD management warrants further investigation.

Purpose of the Study:

• To evaluate the clinical profile of patients undergoing hemodynamic transesophageal echocardiography (hTEE) after CF-LVAD implantation.
• To determine if hTEE influences clinical management decisions in the intensive care unit (ICU).
• To test the hypothesis that hTEE is used in patients with greater acuity, higher blood product utilization, and longer ICU stays.

Main Methods:

• A retrospective review of 100 consecutive patients who received a CF-LVAD.
• Utilizing a standardized electronic form to document findings and management changes from hTEE.
• Comparing patients who received hTEE with those who did not, analyzing risk scores, perioperative data, and outcomes.

Main Results:

• 41% of CF-LVAD patients received hTEE, predominantly those with higher predicted morbidity and mortality risk.
• The hTEE group exhibited increased intraoperative and postoperative blood product use, longer total hospital stays, and higher mortality rates.
• hTEE findings led to changes in ICU management in 72% of the studies where it was performed.

Conclusions:

• Postoperative hTEE in CF-LVAD patients is primarily indicated in those with a more severe clinical status.
• hTEE is a valuable tool that frequently impacts and guides ICU clinical management decisions in this patient population.
• Further research may explore the cost-effectiveness and specific impact of hTEE on patient outcomes.